Evidence map›Paper›PMID 42130317›Full record

ArticleTropical medicine & international health : TM & IH2026

Practices and Perspectives of Lead Implementers on Implementation of Antimicrobial Resistance Strategic Plan: A Cross-Sectional Descriptive Study in Ethiopia.

Desta Assefa, Mekonnen Damessa, Gemmechu Hasen, Belachew Umeta, Geremew Kinati, Alemseged Beyene Berha, Dessalegn Dadi, Habtewold Deti Waktola, Dereje Kebebe, Sultan Suleman

Abstract read
In one paragraph

Article in Tropical medicine & international health : TM & IH, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Desta AssefaSchool of Pharmacy, Faculty of Health Sciences, Institute of Health, Jimma University, Oromia, Ethiopia.ORCID https://orcid.org/0000-0002-4154-1263
Mekonnen DamessaSchool of Pharmacy, Faculty of Health Sciences, Institute of Health, Jimma University, Oromia, Ethiopia.ORCID https://orcid.org/0000-0002-0740-6113
Gemmechu HasenClinical Trials Directorate, Armauer Hansen Research Institute, Addis Ababa, Ethiopia.ORCID https://orcid.org/0000-0002-1693-0240
Belachew UmetaSchool of Pharmacy, Faculty of Health Sciences, Institute of Health, Jimma University, Oromia, Ethiopia.ORCID https://orcid.org/0000-0002-8420-2253
Geremew KinatiJimma University Laboratory of Drug Quality (JULaDQ), Jimma University, Oromia, Ethiopia.
Alemseged Beyene BerhaDepartment of Pharmacology and Clinical Pharmacy, School of Pharmacy, College of Health Sciences, Addis Ababa University, Addis Ababa, Ethiopia.
Dessalegn DadiDepartment of Environmental Health Science and Technology, Faculty of Public Health, Institute of Health, Jimma University, Oromia, Ethiopia.
Habtewold Deti WaktolaSchool of Pharmacy, Faculty of Health Sciences, Institute of Health, Jimma University, Oromia, Ethiopia.
Dereje KebebeDepartment of Pharmacy, College of Applied Natural Science, Adama Science and Technology University, Oromia, Ethiopia.ORCID https://orcid.org/0000-0002-6531-2748
Sultan SulemanSchool of Pharmacy, Faculty of Health Sciences, Institute of Health, Jimma University, Oromia, Ethiopia.

Funding

Institute of Health, Jimma University
6 · The paper itself

Abstract

backgroundAddressing the escalating threats of antimicrobial resistance (AMR) through developing and implementing context-specific strategy remains a worldwide priority response. However, its adoption and implementation have often been fragmented in low-resource settings and are currently under-researched. This study evaluates the multi-stakeholder perspectives, practices and operational challenges encountered across Ethiopian national lead implementers of the AMR strategic plan in combating AMR.

methodThis cross-sectional, descriptive study recruited seven AMR stakeholders, recognised as lead implementers of the national AMR strategic plan across human, animal and environmental health sectors in Ethiopia. Data were gathered via face-to-face, semi-structured interviews and document review. Then the collected data were transcribed verbatim and thematically analysed.

resultsThe findings reveal the adoption and commencement of implementing the Ethiopian national AMR strategic plan at varying levels across One Health sectors in Ethiopia. While all key informants had positive perspectives towards implementation and were familiar with the strategic objectives, the practices were inconsistent. Among the five strategic objectives, sub-indicators associated with raising awareness, strengthening infection and prevention control practices and optimising antimicrobial use were better implemented with moderate to full engagement of lead implementers (≥ 75%). Meanwhile, no stakeholder initiated new vaccines and drug substances development and environmental risk assessment for antimicrobials yet. The cross-cutting barriers such as weak and fragmented inter-sectoral collaboration, inconsistent follow-up and scarcity of human and financial resources remained hampering effective implementation.

conclusionFindings demonstrated that despite the existence of an AMR tackling strategy and initiatives, implementation and enforcement remain below the level required by the urgency of the AMR situation. It underscores the importance of bridging implementation gaps by prioritising AMR, strengthening equivalent engagement and collaborations, and capacity building.

Indexed as

Anti-Bacterial AgentsAnimalsCross-Sectional StudiesEthiopiaHumansAnti-Bacterial Agentsantimicrobial resistance containmentEthiopiaone healthstakeholder engagement

Identifiers

PMID42130317
PMCPMC13533631

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.